🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a 24-week, prospective, multi-center, open-label, randomized, inves...
Status
Terminated
Location
Toronto Retina Institue
Start Date
2015-11
Trial ID
NCT02684084
The aim of this study is to test if PF582 (ranibizumab) is safe and similar...
Status
Completed
Location
Eye Institute
Start Date
2013-11
Trial ID
NCT02121353
Intravitreal ranibizumab alone was Compared to adding dexamethasone to rani...
Status
Completed
Location
Khaled G Abueleinen
Start Date
2020-07-01
Trial ID
NCT05271539
Treatments Being Tested
The aim of this study is to evaluate the visual outcome and prognostic fact...
Status
Unknown
Location
He Eye Specialist Hospital
Start Date
2020-10-31
Trial ID
NCT04601675
Treatments Being Tested
Background: Age-related macular degeneration (AMD) is a common eye disease ...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-08-01
Trial ID
NCT07744204
Treatments Being Tested
The objective of this clinical trial is to compare and evaluate the safety ...
Status
Unknown
Location
Hallym University Kangnam Sacred Heart Hospital
Start Date
2018-01-08
Trial ID
NCT03759860
The investigators hope to determine if "wet" AMD patients differ from patie...
Status
Completed
Location
University of California, Davis
Start Date
2009-08
Trial ID
NCT00931489
Treatments Being Tested
This study will evaluate and compare two individualized ranibizumab treatme...
Status
Completed
Location
Novartis Investigative Site
Start Date
2013-06-03
Trial ID
NCT01780935
Treatments Being Tested
The purpose of this study is to compare the efficacy (times of injection, c...
Status
Completed
Location
ZhongShan Ophthalmic Center, Sun Yat-sen University
Start Date
2015-04
Trial ID
NCT03042871
Treatments Being Tested
This is a open label, multicenter, Phase II study to evaluate the usability...
Status
Completed
Location
Research site
Start Date
2026-03-30
Trial ID
NCT07550504
Treatments Being Tested